AR046719A1 - Sales de benzazepina y composiciones farmacéuticas que las contienen. - Google Patents
Sales de benzazepina y composiciones farmacéuticas que las contienen.Info
- Publication number
- AR046719A1 AR046719A1 ARP040104393A ARP040104393A AR046719A1 AR 046719 A1 AR046719 A1 AR 046719A1 AR P040104393 A ARP040104393 A AR P040104393A AR P040104393 A ARP040104393 A AR P040104393A AR 046719 A1 AR046719 A1 AR 046719A1
- Authority
- AR
- Argentina
- Prior art keywords
- contain
- pharmaceutical compositions
- salts
- benzazepine
- chlorobenzyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Una sal de bezazepina, composición fármacéutica que comprende una o más de dichas sales, y un vehículo farmacéuticamente aceptable. Reivindicación 1:Una sal de benzazepina caracterizada porque es seleccionada de maleato de 7-[4-(4- clorobenciloxi)bencenosulfonil]-8-metoxi-3-metil-2, 3, 4, 5-tetrahidro-1H-3-benzazepinio de la fórmula 1 y uno de sus solvatos farmacéuticamente aceptables; y tosilato de 7-[4-(4-clorobenciloxi)-bencenosulfonil]-8-metoxi-3-metil-2, 3, 4, 5- tetrahidro-1H-3-benzazepinio de la fórmula 2 y uno de sus solvatos farmacéuticamente aceptables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0327740.7A GB0327740D0 (en) | 2003-11-28 | 2003-11-28 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046719A1 true AR046719A1 (es) | 2005-12-21 |
Family
ID=29798028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104393A AR046719A1 (es) | 2003-11-28 | 2004-11-26 | Sales de benzazepina y composiciones farmacéuticas que las contienen. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070275948A1 (es) |
| EP (1) | EP1687279A1 (es) |
| JP (1) | JP2007512285A (es) |
| KR (1) | KR20060103322A (es) |
| CN (1) | CN1906170A (es) |
| AR (1) | AR046719A1 (es) |
| AU (1) | AU2004293179A1 (es) |
| BR (1) | BRPI0417029A (es) |
| CA (1) | CA2547444A1 (es) |
| GB (1) | GB0327740D0 (es) |
| IL (1) | IL175663A0 (es) |
| IS (1) | IS8500A (es) |
| MA (1) | MA28177A1 (es) |
| NO (1) | NO20062970L (es) |
| RU (1) | RU2006122959A (es) |
| TW (1) | TW200528433A (es) |
| WO (1) | WO2005051916A1 (es) |
| ZA (1) | ZA200603781B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0510599D0 (en) * | 2005-05-24 | 2005-06-29 | Glaxo Group Ltd | Novel compounds |
| GB0603087D0 (en) * | 2006-02-15 | 2006-03-29 | Glaxo Group Ltd | Novel use |
| NZ586675A (en) * | 2008-01-08 | 2012-04-27 | Merck Sharp & Dohme | Pharmaceutically acceptable salts of 2-{ 4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide |
| EP3229908A4 (en) * | 2014-12-12 | 2018-06-27 | Schepens Eye Research Institute. Inc. | Gdnf induction for the treatment of retinal disorders |
| CA3052479A1 (en) | 2017-02-17 | 2018-08-23 | Trevena, Inc. | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| WO2022093904A1 (en) * | 2020-10-27 | 2022-05-05 | Trevena, Inc. | Crystalline and amorphous forms of a delta-opioid modulator |
| CN115998724B (zh) * | 2023-03-28 | 2023-06-16 | 中国人民解放军军事科学院军事医学研究院 | 布洛芬在抗幻觉作用药物中的新用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1456178A1 (en) * | 2001-12-21 | 2004-09-15 | Smithkline Beecham Plc | 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders |
| EP1474399A1 (en) * | 2002-02-13 | 2004-11-10 | Glaxo Group Limited | Benzenesulfonamide derivatives as antipsychotic agents |
| TWI281914B (en) * | 2002-05-29 | 2007-06-01 | Glaxo Group Ltd | Compounds |
-
2003
- 2003-11-28 GB GBGB0327740.7A patent/GB0327740D0/en not_active Ceased
-
2004
- 2004-11-25 KR KR1020067010371A patent/KR20060103322A/ko not_active Application Discontinuation
- 2004-11-25 EP EP04819223A patent/EP1687279A1/en not_active Withdrawn
- 2004-11-25 CA CA002547444A patent/CA2547444A1/en not_active Abandoned
- 2004-11-25 RU RU2006122959/04A patent/RU2006122959A/ru not_active Application Discontinuation
- 2004-11-25 US US10/580,640 patent/US20070275948A1/en not_active Abandoned
- 2004-11-25 AU AU2004293179A patent/AU2004293179A1/en not_active Abandoned
- 2004-11-25 JP JP2006540389A patent/JP2007512285A/ja active Pending
- 2004-11-25 CN CNA2004800410778A patent/CN1906170A/zh active Pending
- 2004-11-25 WO PCT/EP2004/013416 patent/WO2005051916A1/en active Application Filing
- 2004-11-25 BR BRPI0417029-6A patent/BRPI0417029A/pt not_active IP Right Cessation
- 2004-11-26 TW TW093136389A patent/TW200528433A/zh unknown
- 2004-11-26 AR ARP040104393A patent/AR046719A1/es not_active Application Discontinuation
-
2006
- 2006-05-10 ZA ZA200600378A patent/ZA200603781B/xx unknown
- 2006-05-16 IL IL175663A patent/IL175663A0/en unknown
- 2006-05-24 MA MA29055A patent/MA28177A1/fr unknown
- 2006-06-08 IS IS8500A patent/IS8500A/xx unknown
- 2006-06-26 NO NO20062970A patent/NO20062970L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IS8500A (is) | 2006-06-08 |
| NO20062970L (no) | 2006-08-21 |
| CN1906170A (zh) | 2007-01-31 |
| GB0327740D0 (en) | 2003-12-31 |
| AU2004293179A1 (en) | 2005-06-09 |
| BRPI0417029A (pt) | 2007-02-06 |
| US20070275948A1 (en) | 2007-11-29 |
| TW200528433A (en) | 2005-09-01 |
| CA2547444A1 (en) | 2005-06-09 |
| ZA200603781B (en) | 2007-09-26 |
| JP2007512285A (ja) | 2007-05-17 |
| RU2006122959A (ru) | 2008-01-10 |
| IL175663A0 (en) | 2006-09-05 |
| MA28177A1 (fr) | 2006-09-01 |
| WO2005051916A1 (en) | 2005-06-09 |
| KR20060103322A (ko) | 2006-09-28 |
| EP1687279A1 (en) | 2006-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200702498A1 (ru) | N-(пиридин-2-ил)сульфонамидные производные | |
| IL149163A0 (en) | Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them | |
| ATE371656T1 (de) | Heteroaryl-pyrimidinderivate als jak-inhibitoren | |
| DK1263730T3 (da) | Aminderivater til behandling af apoptose | |
| EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
| ECSP034914A (es) | "azaindoles" | |
| NO20032905L (no) | Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister | |
| DE60330187D1 (de) | Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen | |
| CY1108522T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
| ATE394383T1 (de) | Biphenylkarbonsäureamidderivate als p38 kinase- inhibitoren | |
| CO5690551A2 (es) | Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo | |
| BR0208741A (pt) | Derivados de piperidina | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| FI970317A0 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| ATE516016T1 (de) | Selbstemulgierende formulierungen von cetp- hemmern | |
| ATE356130T1 (de) | Inhibitoren von cruzipain und anderen cysteinproteasen | |
| ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
| DE60313350D1 (de) | Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer | |
| DE60112306D1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| AR046719A1 (es) | Sales de benzazepina y composiciones farmacéuticas que las contienen. | |
| DK1307445T3 (da) | Benzofuranderivater og deres anvendelse som antibakterielle midler | |
| SE0402284D0 (sv) | New heterocyclic amides | |
| AR044720A1 (es) | Una sulfonamida heterociclica, su uso, un proceso para prepararla, una composicion farmaceutica que la comprende, y compuestos utiles como intermediari0s | |
| ATE337320T1 (de) | Indolderivate als pde5-inhibitoren | |
| ATE274515T1 (de) | Pyrazolopyridinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |